Facebook
Twitter
LinkedIn
Forward2021 Updates in Hematologic Malignancies
The 2021 Updates in Hematologic Malignancies features leading experts in the field, comprehensive clinical content, and the opportunity to interact with colleagues. Participants will have a chance to hear experts' perspectives on novel treatment strategies and management of treatment-related toxicities in the management of patients with hematologic malignancies. This activity aims to improve the knowledge, competence, and performance of healthcare professionals in the evidence-based management of hematologic malignancies.
Abstract Presentations
Abstract Presentation Schedule has been emailed to all accepted abstract authors.
All presenters must be fully vaccinated against COVID-19 to be able to present their abstracts.
You must be registered for the conference to present your abstract. If you are a resident or fellow presenting the abstract, please follow the instructions for fellow/resident registration to receive a registration fee waiver.
Target Audience
- Hematologists/Oncologists
- Oncology Nurse Practitioners
- Oncology Pharmacists
- Oncology Physician Assistants
- Oncology Fellows/Residents
- Oncology Nurses
- Researchers and others involved in the care of cancer patients
COVID-19 precautions:
COVID-19 Vaccinations required to attend - Each person attending this meeting must be fully vaccinated against COVID-19 to be able to attend this conference. A proof of vaccination may be requested at the time of check-in.
Masks Required to Attend - We also ask that each attendee wear a mask while indoors. We will provide disposable masks if you forget to bring yours.
Learning Objectives
Upon successful completion of this educational activity, participants will be able to:
- Review pertinent clinical trial data for the standard of care and novel management strategies for various hematologic malignancies.
- Integrate and optimally sequence evidence-based treatment plans for various hematologic malignancies based on patient and tumor factors.
- Discuss the mechanism of action, efficacy, indications, and safety of novel targeted therapies and cellular therapies for the management of hematologic malignancies.
- Review current controversies in the management of various hematologic malignancies.
- List appropriate clinical trials for hematologic malignancies
Conference Chair: Srinivas Tantravahi, MD
All times are listed in local venue time zone (Mountain Time)
6:30 AM to 7:45 AM Breakfast and Registration
7:45 AM to 8:00 AM Opening Remarks
8:00 AM to 9:30 AM Session 1: Lymphomas
Moderator: Lindsay Fitzgerald, MD
8:00 AM to 8:30 AM Hodgkin lymphoma – Harsh Shah, DO
8:30 AM to 9:00 AM Aggressive lymphomas – Ryan Lynch, MD
9:00 AM to 9:30 AM Chronic lymphocytic leukemia – Deborah Stephens, DO
9:30 AM to 10:00 AM CAR-T cell therapy for the treatment of Lymphoma –
Catherine Lee, MD
10:00 AM to 10:30 AM BREAK
10:00 AM to 10:30 AM Breakfast and Learn with Dr. Amit Mehta in the Topaz Room*
Stand Strong Against Platelet Destruction with TAVALISSE: A Patient’s ITP Treatment Journey
Presented by - Rigel Pharmaceuticals, Inc.
*This program is not part of the CME activity.
10:30 AM to 12:00 PM Session 2: Leukemias
Moderator: Ashley Newland, PharmD
10:30 AM to 11:00 AM Acute Myeloid Leukemia – Krishna Gundabolu, MD
10:30 AM to 11:00 AM Acute lymphoblastic leukemia – Tibor Kovacsovics, MD
11:30 AM - 12:00 PM Case based discussion
Case 1: Charlotte Wagner, PharmD
12:00 PM - 01:00 PM LUNCH
01:00 AM - 03:00 PM Session 3: Multiple Myeloma
Moderator: Douglas Sborov, MD
01:00 PM to 01:30 PM Front line therapy for newly diagnosed multiple myeloma –
Ghulam Mohyuddin, MD
01:30 PM to 02:00 PM Treatment of relapse/refractory multiple myeloma –
Shaji Kumar, MD
02:00 PM to 02:30 PM Case - based discussion
Case 1: Mary Steinbach, APRN
Case 2: Aman Godara, MD
02:30 PM to 03:00 PM BREAK
03:00 PM to 04:30 PM Session 4: Myeloproliferative Neoplasms
Moderator: Tashi Tsewang, MD and Laura Bickel, APRN
03:00 PM to 03:30 PM Myeloproliferative neoplasms – Srinivas Tantravahi, MD
03:30 PM to 04:00 PM Treatment free remission in chronic myeloid leukemia –
Jerry Radich, MD
04:30 - 05:00 pm Case - based discussion
Case: Laura Bickel, APRN
5:00 PM to 6:00 PM - ABSTRACT SESSION in Topaz room
 | Srinivas Tantravahi, MDAssistant Professor of Medicine University of Utah |  | Jerald Radich, MDProfessor of Medicine University of Washington, SCCA, Fred Hutch |
 | Amandeep Godara, MDAssistant Professor of Medicine Huntsman Cancer Institute, University of Utah |  | Tsewang Tashi, MDAssistant Professor of Medicine Huntsman Cancer Institute, University of Utah |
 | Krishna Gundabolu, MDAssistant Professor of Medicine University of Nebraska | ||
 | Harsh Shah, DOAssistant Professor of Medicine Huntsman Cancer Institute, University of Utah | Ryan Lynch, MDAssistant Professor of Medicine University of Washington Medical-Oncologist Seattle Cancer Care Alliance | |
 |
Deborah Stephens, DOAssistant Professor of Medicine Huntsman Cancer Institute, University of Utah |  | Catherine Lee, MDAssistant Professor of Medicine Huntsman Cancer Institute, University of Utah |
 | Tibor Kovacsovics, MDProfessor of Medicine Huntsman Cancer Institute, University of Utah |  | Douglas Sborov, MDAssistant Professor of Medicine Huntsman Cancer Institute, University of Utah |
 |
Shaji Kumar, MDProfessor of Medicine Mayo Clinic | Photo coming soon! | Charolette Wagner, PharmDHuntsman Cancer Institute, University of Utah |
 | Laura Bickel, APRNAdvanced Practice Clinician Huntsman Cancer Institute, University of Utah |  | Mary Steinbach, APRNAdvanced Practice Clinician Huntsman Cancer Institute, University of Utah |
The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians.
The Binaytara Foundation designates this live activity for a maximum of 6.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity meets the criteria for up to 6.5 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
Nursing Contact Hours: Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 6.5 Contact Hours.
ABSM Maintenance of Certificate Recognition Statement: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.5 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Acknowledgment of commercial support
This activity has been supported with independent medical education grant(s) from the following companies:
Pfizer, Inc.
Available Credit
- 6.50 ABIM MOC IISuccessful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.50 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
- 6.50 AMA PRA Category 1 Credit™The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 6.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 6.50 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
- 6.50 Nursing Contact HoursProvider approved by the California Board of Registered Nursing, Provider # CEP17035, for 6.50 Contact Hours.
We have exhibit & Industry Sponsored Symposia opportunities available at this meeting. You can sign up to exhibit both days (2021 Precision Oncology Summit: Personalizing treatment to improve patient outcomes) & 2021 Updates in Hematologic Malignancies or only one day.
Register to exhibit at this conference here - Salt Lake City Conference Exhibit Registration
Contact Tara Shah if you have any questions.
PLEASE VISIT OUR EXHIBITORS BELOW DURING THE EXHIBIT/BREAK/LUNCH HOURS.
Price
COVID-19 precautions:
COVID-19 Vaccinations required to attend - Each person attending this meeting must be fully vaccinated against COVID-19 to be able to attend this conference. A proof of vaccination may be requested at the time of check-in.
Masks Required to Attend - We also ask that each attendee wear a mask while indoors. We will provide disposable masks if you forget to bring yours.
REGISTRATION FEES DETAILS
Physicians (MD/DO) - $200
Non-Physician (RN/NP/PA/PharmD) - $125
Residents/Fellows - Free registration - see instructions below*
*If you are a resident or fellow in the United States, please create a user account on this portal using your work email, and send us an email from the email address used to create the account with the name of the conference(s) that you are interested in attending, and we will register you for free.
*If you are a resident or fellow from outside the United States, please create a user account on this portal using your work email if available, and send us an email from the email address used to create the account with the following information, and we will register you for free.
- Name of the conference(s) that you are interested in attending
- A picture ID or another document showing proof of your status as Resident/Fellow/Physician in training
- Name and email address of program director to verify your trainee status
Non-displaying industry representative - $500
Displaying industry representative (not covered by the display fee) - $300
If you are employed by the industry, you must register as "Industry representative" even if you are a licensed healthcare provider not involved in the sales of product. The industry price is applicable to everyone who are employed by an ACCME defined ineligible company.